Modern Retina

The leading source for #Retina. We cover AMD, DME, diabetic retinopathy, uveitis, and more. Follow our parent publication @OphthTimes.

[Modern Retina @ModernRetina]

How are next-generation anti-VEGF agents changing care in AMD, DME, and RVO? Sharon Fekrat, MD, FACS, FASRS, and an expert panel discuss the real-world performance, durability, and safety of aflibercept 8 mg and faricimab. Watch now: https://t.co/WOXWmHX6Tt #Retina #AntiVEGF

[Modern Retina @ModernRetina]

As aesthetic injectables continue to grow in popularity, retina specialists are increasingly likely to encounter patients considering these procedures. Watch the latest episode of The Retina TL;DR to learn more: https://t.co/7c6A1iDtVs

[Modern Retina @ModernRetina]

Jennifer Murdock, MD, joins The Retina TL;DR with Christina Y. Weng, MD, MBA, FASRS, to discuss filler-related ocular complications, high-risk injection sites, emergency management strategies, and more. Watch now: https://t.co/5qWPIGeG4q

[Modern Retina @ModernRetina]

Watch Christina Y. Weng, MD, MBA, FASRS, and her guest Jennifer Murdock, MD, discuss anatomy, vascular occlusion risk, and periocular filler safety in the latest episode of The Retina TL;DR: https://t.co/rK30NH1d8d

[Modern Retina @ModernRetina]

Prevent Blindness has designated April as Women’s Eye Health and Safety Month. We are proud to support this initiative and highlight the voices shaping the future of care. Explore insights from female key opinion leaders whose recent work is featured on our platforms.

[Modern Retina @ModernRetina]

We are hosting two events for retina specialists in Fort Lauderdale, FL, on May 15. Participants will receive $500 in compensation. Learn more and join us!
Geographic Atrophy Roundtable: https://t.co/Om5ahXElhd
Anti-VEGF Roundtable: https://t.co/84AUVkPU5C

[Modern Retina @ModernRetina]

Honoring the women who are shaping the future of vision. From groundbreaking research to everyday patient care, their leadership and dedication continue to move the field forward. This Women’s History Month, we recognize their impact across every corner of eye care.

[Modern Retina @ModernRetina]

Check out the latest issue of Modern Retina! Read about how AI is reshaping ophthalmology, mitigating severe vision loss, multimodal imaging for AMD and GA, as well as mentorship, momentum, and a retina podcast.

Read now: https://t.co/ysbi4bif3E

#Retina #VisionLoss #AMD #GA

[Modern Retina @ModernRetina]

Disease mechanisms and treatment goals differ across AMD, DME, and RVO. Our expert panel reviews clinical nuances and how they guide the choice of next-generation anti-VEGF therapy.
Watch the discussion: https://t.co/F3kQy2OYJo
#Retina #Ophthalmology

[Modern Retina @ModernRetina]

Our latest issue is live! Read about the science powering next-generation retinal treatments, custom programs for managing Macular Telangiectasia, and treatment options for reducing fluid fluctuation in retinal disorders.

Read now: https://t.co/hHjPk27uT5

#Retina #MacTel

[Modern Retina @ModernRetina]

How are next-generation anti-VEGF agents changing care in AMD, DME, and RVO? Sharon Fekrat, MD, FACS, FASRS, and an expert panel discuss the real-world performance, durability, and safety of aflibercept 8 mg and faricimab.
Watch now: https://t.co/ZOBoo24a95
#Retina #AntiVEGF

[Modern Retina @ModernRetina]

Wishing you a season filled with clear moments and bright perspectives. 🎄👁️
Thank you to the retina specialists whose precision and dedication protect sight at its most critical level, today and all year long.

#EyeCareProfessionals #RetinaCare #HappyHolidays

[Modern Retina @ModernRetina]

Grateful for the eye-care professionals who bring clarity, comfort, and better vision to patients every day. Wishing you a spec-tacular 👓 and restorative Thanksgiving! 🦃

#thanksgiving #eyecare

[Modern Retina @ModernRetina]

Coave Therapeutics has announced its lead gene therapy program, CoTx-10, for the treatment of retinal vascular diseases, such as wet age-related macular degeneration (wAMD) and diabetic macular edema (DME). https://t.co/OWZfO566ou

[Modern Retina @ModernRetina]

Stephen Tsang, MD, PhD, reviews promising optogenetic therapy results for retinitis pigmentosa and Stargardt disease, enhancing vision and mobility for patients. https://t.co/6KSZD9ZCzM

[Modern Retina @ModernRetina]

Eichenbaum Acorns: A leadership conversation with Rishi P. Singh, MD, FASRS, on advancing CME: https://t.co/TQiONmqJPr

[Modern Retina @ModernRetina]

Q&A: Kenneth Fan on MCO-010 trials for Stargardt disease: https://t.co/9jvpzl5aur

[Modern Retina @ModernRetina]

Foundation Fighting Blindness releases 4-year RUSH2A data to public: https://t.co/2xsrjyjZzk

[Modern Retina @ModernRetina]

Post-hoc AREDS2 analysis highlights distinct mechanisms driving GA progression: https://t.co/1PJrL2J2Ju

[Modern Retina @ModernRetina]

Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial: https://t.co/4BVbKpc8cE